StockNews.com Upgrades Quest Diagnostics (NYSE:DGX) to Buy
StockNews.com Upgrades Quest Diagnostics (NYSE:DGX) to Buy
StockNews.com upgraded shares of Quest Diagnostics (NYSE:DGX – Get Rating) from a hold rating to a buy rating in a research report report published on Tuesday morning.
在周二上午发布的一份研究报告中，StockNews.com将Quest Diagnostics(NYSE：DGX-GET Rating)的股票评级从持有评级上调至买入评级。
Separately, Morgan Stanley reiterated an equal weight rating and issued a $142.00 price target on shares of Quest Diagnostics in a report on Monday, August 22nd. Six investment analysts have rated the stock with a hold rating and three have given a buy rating to the company's stock. According to data from MarketBeat, the company currently has a consensus rating of Hold and a consensus target price of $148.50.
另外，摩根士丹利在8月22日周一的一份报告中重申了同等权重的评级，并对Quest Diagnostics的股票发布了142.00美元的目标价。六名投资分析师对该股的评级为持有，三名分析师对该公司股票的评级为买入。根据MarketBeat的数据，该公司目前的共识评级为持有，共识目标价为148.50美元。
Quest Diagnostics Trading Down 1.5 %
Quest Diagnostics降价1.5%
Shares of DGX opened at $122.69 on Tuesday. The company has a current ratio of 1.54, a quick ratio of 1.42 and a debt-to-equity ratio of 0.62. The firm has a market capitalization of $14.31 billion, a P/E ratio of 10.41 and a beta of 1.01. The stock's fifty day simple moving average is $130.82 and its 200 day simple moving average is $134.90. Quest Diagnostics has a twelve month low of $120.40 and a twelve month high of $174.16.
周二，DGX的股价开盘报122.69美元。该公司的流动比率为1.54，速动比率为1.42，债务权益比率为0.62。该公司的市值为143.1亿美元，市盈率为10.41，贝塔系数为1.01。该股的50日简单移动均线切入位为130.82美元，200日简单移动均线切入位为134.90美元。Quest Diagnostics的12个月低点为120.40美元，12个月高位为174.16美元。
Quest Diagnostics Announces Dividend
Quest Diagnostics宣布分红
The firm also recently announced a quarterly dividend, which will be paid on Wednesday, October 19th. Shareholders of record on Tuesday, October 4th will be issued a $0.66 dividend. The ex-dividend date of this dividend is Monday, October 3rd. This represents a $2.64 dividend on an annualized basis and a yield of 2.15%. Quest Diagnostics's dividend payout ratio is currently 21.96%.
该公司最近还宣布了季度股息，将于10月19日星期三支付。10月4日(星期二)登记在册的股东将获得0.66美元的股息。本次股息除息日期为10月3日(星期一)。这意味着年化股息为2.64美元，收益率为2.15%。Quest Diagnostics的股息支付率目前为21.96%。
Insiders Place Their Bets
内部人士下注
In other news, Director Timothy M. Ring sold 2,000 shares of Quest Diagnostics stock in a transaction that occurred on Monday, August 1st. The stock was sold at an average price of $136.04, for a total transaction of $272,080.00. Following the sale, the director now owns 23,933 shares of the company's stock, valued at $3,255,845.32. The transaction was disclosed in a filing with the SEC, which is accessible through this link. 1.70% of the stock is currently owned by corporate insiders.
在其他新闻方面，董事蒂莫西·M·林在8月1日(星期一)的一笔交易中出售了2,000股Quest诊断公司的股票。该股以136.04美元的平均价格出售，总成交金额为272,080.00美元。出售后，董事现在拥有23,933股该公司的股票，价值3,255,845.32美元。这笔交易是在提交给美国证券交易委员会的一份文件中披露的，该文件可通过这个环节。公司内部人士目前持有该公司1.70%的股份。
Institutional Investors Weigh In On Quest Diagnostics
机构投资者参与Quest Diagnostics
Hedge funds have recently made changes to their positions in the business. Northwestern Mutual Wealth Management Co. raised its holdings in shares of Quest Diagnostics by 5.8% during the first quarter. Northwestern Mutual Wealth Management Co. now owns 11,867 shares of the medical research company's stock valued at $1,624,000 after buying an additional 654 shares during the last quarter. Meeder Asset Management Inc. bought a new stake in Quest Diagnostics during the first quarter worth approximately $524,000. NorthCrest Asset Manangement LLC raised its holdings in Quest Diagnostics by 515.2% during the second quarter. NorthCrest Asset Manangement LLC now owns 16,013 shares of the medical research company's stock worth $2,129,000 after purchasing an additional 13,410 shares in the last quarter. Argent Trust Co raised its holdings in Quest Diagnostics by 1.4% during the first quarter. Argent Trust Co now owns 27,237 shares of the medical research company's stock worth $3,728,000 after purchasing an additional 374 shares in the last quarter. Finally, Pinebridge Investments L.P. raised its holdings in Quest Diagnostics by 480.4% during the first quarter. Pinebridge Investments L.P. now owns 98,916 shares of the medical research company's stock worth $13,538,000 after purchasing an additional 81,873 shares in the last quarter. Institutional investors own 88.87% of the company's stock.
对冲基金最近对其在该业务中的头寸进行了调整。西北互惠财富管理公司在第一季度增持了Quest Diagnostics的股票5.8%。西北互惠财富管理公司目前持有这家医疗研究公司11,867股股票，价值1,624,000美元，该公司在上个季度又购买了654股。Meeder资产管理公司在第一季度购买了Quest Diagnostics的新股份，价值约524,000美元。Northcrest Asset Manangement LLC在第二季度将其在Quest Diagnostics的持股增加了515.2%。Northcrest Asset Manangement LLC现在拥有这家医疗研究公司16,013股股票，价值2,129,000美元，上个季度又购买了13,410股。今年第一季度，银色信托公司将其在Quest Diagnostics的持股增加了1.4%。Argent Trust Co目前持有27,237股这家医疗研究公司的股票，价值3,728,000美元，此前该公司在上个季度又购买了374股。最后，Pinebridge Investments L.P.在第一季度将其在Quest Diagnostics的持股增加了480.4%。PineBridge Investments L.P.在上个季度额外购买了81,873股后，现在拥有这家医疗研究公司98,916股股票，价值13,538,000美元。机构投资者持有该公司88.87%的股票。
About Quest Diagnostics
关于Quest诊断公司
(Get Rating)
(获取评级)
Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services.
Quest诊断公司在美国和国际上提供诊断测试、信息和服务。该公司开发和提供诊断信息服务，如常规测试、非常规和高级临床测试、解剖病理测试和其他诊断信息服务。
Featured Articles
专题文章
- Get a free copy of the StockNews.com research report on Quest Diagnostics (DGX)
- EV Battery Maker Freyr Set For Major Global Expansion
- MarketBeat: Week in Review 9/26 – 9/30
- This Is A Memorable Time To Buy Into Micron Technology
- Thor Industries Hammers Out A Bottom
- How Does Keurig Dr Pepper Compare To Larger Rivals Coke & Pepsi?
- 免费获取StockNews.com关于Quest Diagnostics(DGX)的研究报告
- 电动汽车电池制造商Freyr将在全球大举扩张
- MarketBeat：回顾一周9/26-9/30
- 这是买入美光科技的难忘时刻
- 雷神工业走出谷底
- Keurig Dr Pepper与规模更大的竞争对手可口可乐(Coke&Pepsi)相比如何？
Receive News & Ratings for Quest Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quest Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.
接收Quest诊断日报的新闻和评级-在下面输入您的电子邮件地址，通过MarketBeat.com的免费每日电子邮件时事通讯接收对Quest Diagnostics和相关公司的最新新闻和分析师评级的每日简明摘要。